Considering the activation of TH2 signaling, augmentation of keratinocyte-derived cytokines, and following skin inflammation, it is plausible that these AD-like characteristics and lipid changes induced by IL-17 occur as a secondary mechanism through activation of type 2 inflammation. The gene discussed is IL17A; the disease is Alzheimer disease.